✦ LIBER ✦

Buserelin as primary therapy in advanced prostatic carcinoma

✍ Scribed by Cary A. Presant; Mark S. Soloway; Sol S. Klioze; John W. Kosola; Alun L. Yakabow; Rafael G. Mendez; Peter S. Kennedy; Melody R. Wyres; Virginia L. Naessig; Kimball S. Ford; Charles L. Wiseman; Armand Bouzaglou; Barton Tanenbaum; Daniel Eventov

Publisher: John Wiley and Sons
Year: 1985
Tongue: English
Weight: 369 KB
Volume: 56
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19851115)56:10<2416::aid-cncr2820561013>3.0.co;2-#

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adrenalectomy and hypophysectomy in adva

Adrenalectomy and hypophysectomy in advanced prostatic carcinoma

✍ Gustavo Reynoso; Gerald P. Murphy 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Testosterone potentiated 32P therapy in

Testosterone potentiated 32P therapy in prostatic carcinoma

✍ Robert M. Donati; Harry Ellis; Neil I. Gallagher 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB 👁 1 views

External beam radiation therapy of prima

External beam radiation therapy of primary carcinoma of the prostate

✍ Malcolm A. Bagshaw; Gordon R. Ray; David A. Pistenma; Ronald A. Castellino; Edwi 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

Thalidomide–dexamethasone as primary the

Thalidomide–dexamethasone as primary therapy for advanced multiple myeloma

✍ Michael Wang; Donna M. Weber; Kay Delasalle; Raymond Alexanian 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

## Abstract The value of thalidomide–dexamethasone was assessed in 26 consecutive, previously untreated patients with multiple myeloma of high tumor mass. All showed Hgb < 8.5 g/dL, serum calcium > 11.5 mg/dL, or both. The response rate was 73%, frequency of early death < 3 months was 5%, projected

Tamoxifen in advanced prostatic carcinom

Tamoxifen in advanced prostatic carcinoma. A dose escalation study

✍ Frank M. Torti; Bert L. Lum; Richard Lo; Fuad Freiha; Linda Shortliffe 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 431 KB 👁 2 views

Patients with advanced prostatic carcinoma who had received minimal or no prior therapy were treated with tamoxifen citrate in escalating doses from 10 to 50 mg orally twice a day. Twenty-nine courses were evaluated in 17 patients. Entry was limited to patients with measurable sites of disease. Ther

Total body irradiation (TBI) as primary

Total body irradiation (TBI) as primary therapy for advanced lymphosarcoma

✍ Ralph E. Johnson 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 English ⚖ 382 KB 👁 1 views

The natural history of lymphocytic lymphomas is such that diffuse involvement usually is present at diagnosis. Extensive lymphatic irradiation with tumoricidal doses is seldom an appropriate form of treatment, as most patients require systemic therapy. W e have investigated total body irradiation(TB